{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T05:18:42Z","timestamp":1776143922930,"version":"3.50.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,17]]},"DOI":"10.7759\/cureus.64771","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T03:11:43Z","timestamp":1721272303000},"source":"Crossref","is-referenced-by-count":2,"title":["Pathogenesis and Mechanism of Uremic Vascular Calcification"],"prefix":"10.7759","author":[{"given":"Yingjing","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz133","article-title":"Valvular heart disease and calcification in CKD: More common than appreciated","volume":"35","author":"Ure\u00f1a-Torres P","year":"2020","unstructured":"Ure\u00f1a-Torres P, D'Marco L, Raggi P, et al.. Valvular heart disease and calcification in CKD: More common than appreciated. Nephrol Dial Transplant. 2020, 35:2046-53. 10.1093\/ndt\/gfz133","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000505717","article-title":"Aortic calcification and arterial stiffness burden in a chronic kidney disease cohort with high cardiovascular risk: Baseline characteristics of the impact of phosphate reduction on vascular end-points in Chronic Kidney Disease Trial","volume":"51","author":"Lioufas NM","year":"2020","unstructured":"Lioufas NM, Pedagogos E, Hawley CM, et al.. Aortic calcification and arterial stiffness burden in a chronic kidney disease cohort with high cardiovascular risk: Baseline characteristics of the impact of phosphate reduction on vascular end-points in Chronic Kidney Disease Trial. Am J Nephrol. 2020, 51:201-15. 10.1159\/000505717","journal-title":"Am J Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV22006","article-title":"Role of chronic kidney disease (CKD)-mineral and bone disorder (MBD) in the pathogenesis of cardiovascular disease in CKD","volume":"30","author":"Yamada S","year":"2023","unstructured":"Yamada S, Nakano T. Role of chronic kidney disease (CKD)-mineral and bone disorder (MBD) in the pathogenesis of cardiovascular disease in CKD. J Atheroscler Thromb. 2023, 30:835-50. 10.5551\/jat.RV22006","journal-title":"J Atheroscler Thromb"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham AL","year":"2018","unstructured":"Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: Implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018, 114:590-600. 10.1093\/cvr\/cvy010","journal-title":"Cardiovasc Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1120308","article-title":"Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker","volume":"14","author":"Williams MJ","year":"2023","unstructured":"Williams MJ, White SC, Joseph Z, Hruska KA. Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker. Front Physiol. 2023, 14:1120308. 10.3389\/fphys.2023.1120308","journal-title":"Front Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115542","article-title":"The role of bone morphogenetic protein signaling in vascular calcification","volume":"141","author":"Yang P","year":"2020","unstructured":"Yang P, Troncone L, Augur ZM, Kim SS, McNeil ME, Yu PB. The role of bone morphogenetic protein signaling in vascular calcification. Bone. 2020, 141:115542. 10.1016\/j.bone.2020.115542","journal-title":"Bone"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00777-1","article-title":"Chronic kidney disease-mineral and bone disorders: Pathogenesis and management","volume":"108","author":"Cannata-And\u00eda JB","year":"2021","unstructured":"Cannata-And\u00eda JB, Mart\u00edn-Carro B, Mart\u00edn-V\u00edrgala J, Rodr\u00edguez-Carrio J, Bande-Fern\u00e1ndez JJ, Alonso-Montes C, Carrillo-L\u00f3pez N. Chronic kidney disease-mineral and bone disorders: Pathogenesis and management. Calcif Tissue Int. 2021, 108:410-22. 10.1007\/s00223-020-00777-1","journal-title":"Calcif Tissue Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102046","article-title":"The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): Challenging old concepts with new facts","volume":"11","author":"Viegas C","year":"2019","unstructured":"Viegas C, Ara\u00fajo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): Challenging old concepts with new facts. Aging (Albany NY). 2019, 11:4274-99. 10.18632\/aging.102046","journal-title":"Aging (Albany NY)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021101327","article-title":"Interventions to attenuate vascular calcification progression in chronic kidney disease: A systematic review of clinical trials","volume":"33","author":"Xu C","year":"2022","unstructured":"Xu C, Smith ER, Tiong MK, Ruderman I, Toussaint ND. Interventions to attenuate vascular calcification progression in chronic kidney disease: A systematic review of clinical trials. J Am Soc Nephrol. 2022, 33:1011-32. 10.1681\/ASN.2021101327","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012223","article-title":"Mineral bone disorders in kidney disease patients: The ever-current topic","volume":"23","author":"Hu L","year":"2022","unstructured":"Hu L, Napoletano A, Provenzano M, Garofalo C, Bini C, Comai G, La Manna G. Mineral bone disorders in kidney disease patients: The ever-current topic. Int J Mol Sci. 2022, 23:12223. 10.3390\/ijms232012223","journal-title":"Int J Mol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.06.011","article-title":"Calciphylaxis and kidney disease: A review","volume":"81","author":"Gallo Marin B","year":"2023","unstructured":"Gallo Marin B, Aghagoli G, Hu SL, Massoud CM, Robinson-Bostom L. Calciphylaxis and kidney disease: A review. Am J Kidney Dis. 2023, 81:232-9. 10.1053\/j.ajkd.2022.06.011","journal-title":"Am J Kidney Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X20984525","article-title":"Calcifying characteristics of peripheral vascular smooth muscle cells of chronic kidney disease patients with critical limb ischemia","volume":"26","author":"Lee DO","year":"2021","unstructured":"Lee DO, Kim JH, Kang HW, Kim DY, Lee W, Cho TJ, Lee DY. Calcifying characteristics of peripheral vascular smooth muscle cells of chronic kidney disease patients with critical limb ischemia. Vasc Med. 2021, 26:139-46. 10.1177\/1358863X20984525","journal-title":"Vasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-03-22-6365","article-title":"Chronic kidney disease mineral and bone disorder: A guide for general practice","volume":"52","author":"Sridharan K","year":"2023","unstructured":"Sridharan K. Chronic kidney disease mineral and bone disorder: A guide for general practice. Aust J Gen Pract. 2023, 52:52-7. 10.31128\/AJGP-03-22-6365","journal-title":"Aust J Gen Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065325","article-title":"Mouse models of mineral bone disorders associated with chronic kidney disease","volume":"24","author":"Zaloszyc A","year":"2023","unstructured":"Zaloszyc A, Bernardor J, Bacchetta J, Laverny G, Schmitt CP. Mouse models of mineral bone disorders associated with chronic kidney disease. Int J Mol Sci. 2023, 24:5325. 10.3390\/ijms24065325","journal-title":"Int J Mol Sci"},{"key":"ref15","article-title":"High phosphate diet-induced primary hyperparathyroidism: An animal model","volume":"110","author":"Demeter JG","year":"1991","unstructured":"Demeter JG, De Jong SA, Oslapas R, et al.. High phosphate diet-induced primary hyperparathyroidism: An animal model. Surgery. 1991, 110:1053-60.","journal-title":"Surgery"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.domaniend.2011.09.001","article-title":"Rabbit model of primary hyperparathyroidism induced by high-phosphate diet","volume":"42","author":"Bai RJ","year":"2012","unstructured":"Bai RJ, Cheng XG, Yan D, Qian ZH, Li XM, Qu H, Tian W. Rabbit model of primary hyperparathyroidism induced by high-phosphate diet. Domest Anim Endocrinol. 2012, 42:20-30. 10.1016\/j.domaniend.2011.09.001","journal-title":"Domest Anim Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/BF00261969","article-title":"Characterization of a mouse model of chronic uremia","volume":"16","author":"Gagnon RF","year":"1988","unstructured":"Gagnon RF, Gallimore B. Characterization of a mouse model of chronic uremia. Urol Res. 1988, 16:119-26. 10.1007\/BF00261969","journal-title":"Urol Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4829","article-title":"Dentoalveolar alterations in an adenine-induced chronic kidney disease mouse model","volume":"38","author":"Mohamed FF","year":"2023","unstructured":"Mohamed FF, Amadeu de Oliveira F, Kinoshita Y, et al.. Dentoalveolar alterations in an adenine-induced chronic kidney disease mouse model. J Bone Miner Res. 2023, 38:1192-207. 10.1002\/jbmr.4829","journal-title":"J Bone Miner Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1083725","article-title":"Relative comparison of chronic kidney disease-mineral and bone disorder rat models","volume":"14","author":"Zhang X","year":"2023","unstructured":"Zhang X, Li T, Wang L, et al.. Relative comparison of chronic kidney disease-mineral and bone disorder rat models. Front Physiol. 2023, 14:1083725. 10.3389\/fphys.2023.1083725","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24039","article-title":"Calcitriol combined with high-calcium and high-phosphorus diet induces vascular calcification model in chronic kidney disease rats","volume":"39","author":"Wang Y","year":"2024","unstructured":"Wang Y, Han W, Zhong Y, Li W, Liu Q. Calcitriol combined with high-calcium and high-phosphorus diet induces vascular calcification model in chronic kidney disease rats. Environ Toxicol. 2024, 39:1769-79. 10.1002\/tox.24039","journal-title":"Environ Toxicol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-0919-y","article-title":"High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats","volume":"37","author":"Bisson SK","year":"2019","unstructured":"Bisson SK, Ung RV, Picard S, Valade D, Agharazii M, Larivi\u00e8re R, Mac-Way F. High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats. J Bone Miner Metab. 2019, 37:212-23. 10.1007\/s00774-018-0919-y","journal-title":"J Bone Miner Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1159\/000506013","article-title":"A rat model with multivalve calcification induced by subtotal nephrectomy and high-phosphorus diet","volume":"6","author":"Wang L","year":"2020","unstructured":"Wang L, Tang R, Zhang Y, et al.. A rat model with multivalve calcification induced by subtotal nephrectomy and high-phosphorus diet. Kidney Dis (Basel). 2020, 6:346-54. 10.1159\/000506013","journal-title":"Kidney Dis (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041539","article-title":"Subtotal nephrectomy associated with a high-phosphate diet in rats mimics the development of calcified aortic valve disease associated with chronic renal failure","volume":"12","author":"Messaoudi H","year":"2023","unstructured":"Messaoudi H, Levesque T, Perzo N, et al.. Subtotal nephrectomy associated with a high-phosphate diet in rats mimics the development of calcified aortic valve disease associated with chronic renal failure. J Clin Med. 2023, 12:1539. 10.3390\/jcm12041539","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06021-y","article-title":"Common mouse models of chronic kidney disease are not associated with cachexia","volume":"7","author":"Lair B","year":"2024","unstructured":"Lair B, Lac M, Frassin L, et al.. Common mouse models of chronic kidney disease are not associated with cachexia. Commun Biol. 2024, 7:346. 10.1038\/s42003-024-06021-y","journal-title":"Commun Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-022-02234-y","article-title":"Uremic mouse model to study vascular calcification and \"inflamm-aging\"","volume":"100","author":"T\u00f6lle M","year":"2022","unstructured":"T\u00f6lle M, Henkel C, Herrmann J, et al.. Uremic mouse model to study vascular calcification and \"inflamm-aging\". J Mol Med (Berl). 2022, 100:1321-30. 10.1007\/s00109-022-02234-y","journal-title":"J Mol Med (Berl)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2228920","article-title":"Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease","volume":"45","author":"Yang X","year":"2023","unstructured":"Yang X, Liu Y, Zhu X, et al.. Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease. Ren Fail. 2023, 45:2228920. 10.1080\/0886022X.2023.2228920","journal-title":"Ren Fail"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11040213","article-title":"The key role of phosphate on vascular calcification","volume":"11","author":"Cozzolino M","year":"2019","unstructured":"Cozzolino M, Ciceri P, Galassi A, Mangano M, Carugo S, Capelli I, Cianciolo G. The key role of phosphate on vascular calcification. Toxins (Basel). 2019, 11:213. 10.3390\/toxins11040213","journal-title":"Toxins (Basel)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-021-02037-7","article-title":"Vascular pathologies in chronic kidney disease: Pathophysiological mechanisms and novel therapeutic approaches","volume":"99","author":"D\u00fcsing P","year":"2021","unstructured":"D\u00fcsing P, Zietzer A, Goody PR, Hosen MR, Kurts C, Nickenig G, Jansen F. Vascular pathologies in chronic kidney disease: Pathophysiological mechanisms and novel therapeutic approaches. J Mol Med (Berl). 2021, 99:335-48. 10.1007\/s00109-021-02037-7","journal-title":"J Mol Med (Berl)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03054-z","article-title":"Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia","volume":"76","author":"Voelkl J","year":"2019","unstructured":"Voelkl J, Lang F, Eckardt KU, et al.. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia. Cell Mol Life Sci. 2019, 76:2077-91. 10.1007\/s00018-019-03054-z","journal-title":"Cell Mol Life Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab038","article-title":"From organic and inorganic phosphates to valvular and vascular calcifications","volume":"117","author":"B\u00e4ck M","year":"2021","unstructured":"B\u00e4ck M, Michel JB. From organic and inorganic phosphates to valvular and vascular calcifications. Cardiovasc Res. 2021, 117:2016-29. 10.1093\/cvr\/cvab038","journal-title":"Cardiovasc Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/nu15132918","article-title":"Phosphorus may induce phenotypic transdifferentiation of vascular smooth muscle cells through the reduction of microRNA-145","volume":"15","author":"Fern\u00e1ndez-Villabrille S","year":"2023","unstructured":"Fern\u00e1ndez-Villabrille S, Mart\u00edn-Carro B, Mart\u00edn-V\u00edrgala J, et al.. Phosphorus may induce phenotypic transdifferentiation of vascular smooth muscle cells through the reduction of microRNA-145. Nutrients. 2023, 15:2918. 10.3390\/nu15132918","journal-title":"Nutrients"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2021.03.008","article-title":"Phosphate overload stimulates inflammatory reaction via PiT-1 and induces vascular calcification in uremia","volume":"32","author":"Ding M","year":"2022","unstructured":"Ding M, Zhang Q, Zhang M, et al.. Phosphate overload stimulates inflammatory reaction via PiT-1 and induces vascular calcification in uremia. J Ren Nutr. 2022, 32:178-88. 10.1053\/j.jrn.2021.03.008","journal-title":"J Ren Nutr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166323","article-title":"Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification","volume":"1868","author":"Ishiwata R","year":"2022","unstructured":"Ishiwata R, Morimoto Y. Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification. Biochim Biophys Acta Mol Basis Dis. 2022, 1868:166323. 10.1016\/j.bbadis.2021.166323","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/biom12030350","article-title":"Roles of PI3K\/AKT\/mTOR axis in arteriovenous fistula","volume":"12","author":"Ratti S","year":"2022","unstructured":"Ratti S, Mauro R, Rocchi C, et al.. Roles of PI3K\/AKT\/mTOR axis in arteriovenous fistula. Biomolecules. 2022, 12:350. 10.3390\/biom12030350","journal-title":"Biomolecules"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15813","article-title":"Aldosterone enhances high phosphate-induced vascular calcification through inhibition of AMPK-mediated autophagy","volume":"24","author":"Gao JW","year":"2020","unstructured":"Gao JW, He WB, Xie CM, et al.. Aldosterone enhances high phosphate-induced vascular calcification through inhibition of AMPK-mediated autophagy. J Cell Mol Med. 2020, 24:13648-59. 10.1111\/jcmm.15813","journal-title":"J Cell Mol Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.798053","article-title":"Daprodustat accelerates high phosphate-induced calcification through the activation of HIF-1 signaling","volume":"13","author":"T\u00f3th A","year":"2022","unstructured":"T\u00f3th A, Csiki DM, Nagy B Jr, et al.. Daprodustat accelerates high phosphate-induced calcification through the activation of HIF-1 signaling. Front Pharmacol. 2022, 13:798053. 10.3389\/fphar.2022.798053","journal-title":"Front Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.01092","article-title":"OGT-mediated KEAP1 glycosylation accelerates NRF2 degradation leading to high phosphate-induced vascular calcification in chronic kidney disease","volume":"11","author":"Xu TH","year":"2020","unstructured":"Xu TH, Du Y, Sheng Z, Li Y, Qiu X, Tian B, Yao L. OGT-mediated KEAP1 glycosylation accelerates NRF2 degradation leading to high phosphate-induced vascular calcification in chronic kidney disease. Front Physiol. 2020, 11:1092. 10.3389\/fphys.2020.01092","journal-title":"Front Physiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7150\/thno.87317","article-title":"SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease","volume":"14","author":"Dong QQ","year":"2024","unstructured":"Dong QQ, Tu YC, Gao P, et al.. SGK3 promotes vascular calcification via Pit-1 in chronic kidney disease. Theranostics. 2024, 14:861-78. 10.7150\/thno.87317","journal-title":"Theranostics"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241210016","article-title":"Empagliflozin attenuates vascular calcification in mice with chronic kidney disease by regulating the NFR2\/HO-1 anti-inflammatory pathway through AMPK activation","volume":"24","author":"Lu CW","year":"2023","unstructured":"Lu CW, Lee CJ, Hsieh YJ, Hsu BG. Empagliflozin attenuates vascular calcification in mice with chronic kidney disease by regulating the NFR2\/HO-1 anti-inflammatory pathway through AMPK activation. Int J Mol Sci. 2023, 24:10016. 10.3390\/ijms241210016","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.625215","article-title":"Piperlongumine attenuates high calcium\/phosphate-induced arterial calcification by preserving P53\/PTEN signaling","volume":"7","author":"Shi W","year":"2020","unstructured":"Shi W, Lu J, Li J, et al.. Piperlongumine attenuates high calcium\/phosphate-induced arterial calcification by preserving P53\/PTEN signaling. Front Cardiovasc Med. 2020, 7:625215. 10.3389\/fcvm.2020.625215","journal-title":"Front Cardiovasc Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.12997\/jla.2021.10.1.62","article-title":"Zingerone attenuates Pi-induced vascular calcification via AMPK-mediated TIMP4 expression","volume":"10","author":"Lim YJ","year":"2021","unstructured":"Lim YJ, Min HY, Jang WG. Zingerone attenuates Pi-induced vascular calcification via AMPK-mediated TIMP4 expression. J Lipid Atheroscler. 2021, 10:62-73. 10.12997\/jla.2021.10.1.62","journal-title":"J Lipid Atheroscler"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00833-4","article-title":"RTEF-1 inhibits vascular smooth muscle cell calcification through regulating Wnt\/\u03b2-catenin signaling pathway","volume":"109","author":"Cong J","year":"2021","unstructured":"Cong J, Cheng B, Liu J, He P. RTEF-1 inhibits vascular smooth muscle cell calcification through regulating Wnt\/\u03b2-catenin signaling pathway. Calcif Tissue Int. 2021, 109:203-14. 10.1007\/s00223-021-00833-4","journal-title":"Calcif Tissue Int"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-021-00704-6","article-title":"Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling","volume":"43","author":"Ning FL","year":"2022","unstructured":"Ning FL, Tao J, Li DD, et al.. Activating BK channels ameliorates vascular smooth muscle calcification through Akt signaling. Acta Pharmacol Sin. 2022, 43:624-33. 10.1038\/s41401-021-00704-6","journal-title":"Acta Pharmacol Sin"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0002782022","article-title":"Correction of vascular calcification and hyperphosphatemia in CKD rats treated with ASARM peptide","volume":"3","author":"Rowe PS","year":"2022","unstructured":"Rowe PS, McCarthy EM, Yu AL, Stubbs JR. Correction of vascular calcification and hyperphosphatemia in CKD rats treated with ASARM peptide. Kidney360. 2022, 3:1683-98. 10.34067\/KID.0002782022","journal-title":"Kidney360"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1042\/CS20210259","article-title":"Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling","volume":"135","author":"Feng L","year":"2021","unstructured":"Feng L, Que D, Li Z, et al.. Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling. Clin Sci (Lond). 2021, 135:2483-502. 10.1042\/CS20210259","journal-title":"Clin Sci (Lond)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110477","article-title":"GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt\/\u03b2-catenin signaling pathway","volume":"100","author":"Guo L","year":"2022","unstructured":"Guo L, Wang Y, Li S, Zhou L, Li D. GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt\/\u03b2-catenin signaling pathway. Cell Signal. 2022, 100:110477. 10.1016\/j.cellsig.2022.110477","journal-title":"Cell Signal"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s10735-021-10012-2","article-title":"Globular adiponectin inhibits osteoblastic differentiation of vascular smooth muscle cells through the PI3K\/AKT and Wnt\/\u03b2-catenin pathway","volume":"52","author":"Zhou Y","year":"2021","unstructured":"Zhou Y, Wei LL, Zhang RP, Han CW, Cao Y. Globular adiponectin inhibits osteoblastic differentiation of vascular smooth muscle cells through the PI3K\/AKT and Wnt\/\u03b2-catenin pathway. J Mol Histol. 2021, 52:1067-80. 10.1007\/s10735-021-10012-2","journal-title":"J Mol Histol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12373","article-title":"Intermedin1\u201147 inhibits high phosphate\u2011induced vascular smooth muscle cell calcification by regulating Wnt\/\u03b2\u2011catenin signaling","volume":"24","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Tang N, Zhou J. Intermedin1\u201147 inhibits high phosphate\u2011induced vascular smooth muscle cell calcification by regulating Wnt\/\u03b2\u2011catenin signaling. Mol Med Rep. 2021, 24:733. 10.3892\/mmr.2021.12373","journal-title":"Mol Med Rep"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.4142\/jvs.23148","article-title":"Kalkitoxin attenuates calcification of vascular smooth muscle cells via RUNX-2 signaling pathways","volume":"24","author":"Shrestha SK","year":"2023","unstructured":"Shrestha SK, Kim SW, Soh Y. Kalkitoxin attenuates calcification of vascular smooth muscle cells via RUNX-2 signaling pathways. J Vet Sci. 2023, 24:e69. 10.4142\/jvs.23148","journal-title":"J Vet Sci"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231222156","article-title":"Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1","volume":"52","author":"Zang H","year":"2024","unstructured":"Zang H, Liu Y, Teng Q, Hua J, Peng D, Wang P. Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1. J Int Med Res. 2024, 52:3000605231222156. 10.1177\/03000605231222156","journal-title":"J Int Med Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/nu14132589","article-title":"Vitamin D treatment prevents uremia-induced reductions in aortic microRNA-145 attenuating osteogenic differentiation despite hyperphosphatemia","volume":"14","author":"Carrillo-L\u00f3pez N","year":"2022","unstructured":"Carrillo-L\u00f3pez N, Panizo S, Arcidiacono MV, et al.. Vitamin D treatment prevents uremia-induced reductions in aortic microRNA-145 attenuating osteogenic differentiation despite hyperphosphatemia. Nutrients. 2022, 14:2589. 10.3390\/nu14132589","journal-title":"Nutrients"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118121","article-title":"OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP","volume":"261","author":"Xu TH","year":"2020","unstructured":"Xu TH, Sheng Z, Li Y, Qiu X, Tian B, Yao L. OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy activation by downregulating YAP. Life Sci. 2020, 261:118121. 10.1016\/j.lfs.2020.118121","journal-title":"Life Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13010026","article-title":"Role of uremic toxins in early vascular ageing and calcification","volume":"13","author":"Kyriakidis NC","year":"2021","unstructured":"Kyriakidis NC, Cobo G, Dai L, Lindholm B, Stenvinkel P. Role of uremic toxins in early vascular ageing and calcification. Toxins (Basel). 2021, 13:26. 10.3390\/toxins13010026","journal-title":"Toxins (Basel)"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13588","article-title":"Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease","volume":"51","author":"Rodrigues FG","year":"2021","unstructured":"Rodrigues FG, Ormanji MS, Heilberg IP, Bakker SJ, de Borst MH. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease. Eur J Clin Invest. 2021, 51:e13588. 10.1111\/eci.13588","journal-title":"Eur J Clin Invest"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00736-7","article-title":"Inflammation and gut dysbiosis as drivers of CKD-MBD","volume":"19","author":"Evenepoel P","year":"2023","unstructured":"Evenepoel P, Stenvinkel P, Shanahan C, Pacifici R. Inflammation and gut dysbiosis as drivers of CKD-MBD. Nat Rev Nephrol. 2023, 19:646-57. 10.1038\/s41581-023-00736-7","journal-title":"Nat Rev Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12120812","article-title":"Uremic vascular calcification: The pathogenic roles and gastrointestinal decontamination of uremic toxins","volume":"12","author":"Chao CT","year":"2020","unstructured":"Chao CT, Lin SH. Uremic vascular calcification: The pathogenic roles and gastrointestinal decontamination of uremic toxins. Toxins (Basel). 2020, 12:812. 10.3390\/toxins12120812","journal-title":"Toxins (Basel)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12100624","article-title":"Uremic toxins and vascular calcification-Missing the forest for all the trees","volume":"12","author":"Rapp N","year":"2020","unstructured":"Rapp N, Evenepoel P, Stenvinkel P, Schurgers L. Uremic toxins and vascular calcification-Missing the forest for all the trees. Toxins (Basel). 2020, 12:624. 10.3390\/toxins12100624","journal-title":"Toxins (Basel)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.10.012","article-title":"Lack of endothelial nitric oxide synthase accelerates ectopic calcification in uremic mice fed an adenine and high phosphorus diet","volume":"191","author":"Oe Y","year":"2021","unstructured":"Oe Y, Mitsui S, Sato E, et al.. Lack of endothelial nitric oxide synthase accelerates ectopic calcification in uremic mice fed an adenine and high phosphorus diet. Am J Pathol. 2021, 191:283-93. 10.1016\/j.ajpath.2020.10.012","journal-title":"Am J Pathol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy325","article-title":"Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion","volume":"34","author":"Bouabdallah J","year":"2019","unstructured":"Bouabdallah J, Zibara K, Issa H, et al.. Endothelial cells exposed to phosphate and indoxyl sulphate promote vascular calcification through interleukin-8 secretion. Nephrol Dial Transplant. 2019, 34:1125-34. 10.1093\/ndt\/gfy325","journal-title":"Nephrol Dial Transplant"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2016.1155397","article-title":"Indoxyl sulfate promotes vascular smooth muscle cell calcification via the JNK\/Pit-1 pathway","volume":"38","author":"Wu Y","year":"2016","unstructured":"Wu Y, Han X, Wang L, Diao Z, Liu W. Indoxyl sulfate promotes vascular smooth muscle cell calcification via the JNK\/Pit-1 pathway. Ren Fail. 2016, 38:1702-10. 10.3109\/0886022X.2016.1155397","journal-title":"Ren Fail"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.23369","article-title":"Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"82","author":"He X","year":"2019","unstructured":"He X, Jiang H, Gao F, Liang S, Wei M, Chen L. Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K\/Akt\/NF-\u03baB signaling pathway. Microsc Res Tech. 2019, 82:2000-6. 10.1002\/jemt.23369","journal-title":"Microsc Res Tech"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112301","article-title":"Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS\/NF-\u03baB signaling","volume":"397","author":"He X","year":"2020","unstructured":"He X, Wang Z, Wei L, Cheng X, Chen L, Gao F, Jiang H. Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS\/NF-\u03baB signaling. Exp Cell Res. 2020, 397:112301. 10.1016\/j.yexcr.2020.112301","journal-title":"Exp Cell Res"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12050285","article-title":"The role of gut dysbiosis in the bone-vascular axis in chronic kidney disease","volume":"12","author":"Evenepoel P","year":"2020","unstructured":"Evenepoel P, Dejongh S, Verbeke K, Meijers B. The role of gut dysbiosis in the bone-vascular axis in chronic kidney disease. Toxins (Basel). 2020, 12:285. 10.3390\/toxins12050285","journal-title":"Toxins (Basel)"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam6474","article-title":"Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability","volume":"10","author":"King AJ","year":"2018","unstructured":"King AJ, Siegel M, He Y, et al.. Inhibition of sodium\/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med. 2018, 10:eaam6474. 10.1126\/scitranslmed.aam6474","journal-title":"Sci Transl Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2019.1650065","article-title":"Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients","volume":"41","author":"Mizuiri S","year":"2019","unstructured":"Mizuiri S, Nishizawa Y, Yamashita K, et al.. Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients. Ren Fail. 2019, 41:770-7. 10.1080\/0886022X.2019.1650065","journal-title":"Ren Fail"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-63013-8","article-title":"Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease","volume":"10","author":"Jaminon AM","year":"2020","unstructured":"Jaminon AM, Dai L, Qureshi AR, et al.. Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease. Sci Rep. 2020, 10:6586. 10.1038\/s41598-020-63013-8","journal-title":"Sci Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095282","article-title":"Role of vitamin K in chronic kidney disease: A focus on bone and cardiovascular health","volume":"23","author":"Bellone F","year":"2022","unstructured":"Bellone F, Cinquegrani M, Nicotera R, et al.. Role of vitamin K in chronic kidney disease: A focus on bone and cardiovascular health. Int J Mol Sci. 2022, 23:5282. 10.3390\/ijms23095282","journal-title":"Int J Mol Sci"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.040","article-title":"Vitamin K role in mineral and bone disorder of chronic kidney disease","volume":"502","author":"de Oliveira RB","year":"2020","unstructured":"de Oliveira RB, Stinghen AE, Massy ZA. Vitamin K role in mineral and bone disorder of chronic kidney disease. Clin Chim Acta. 2020, 502:66-72. 10.1016\/j.cca.2019.11.040","journal-title":"Clin Chim Acta"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247623","article-title":"Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study","volume":"16","author":"Dai L","year":"2021","unstructured":"Dai L, Li L, Erlandsson H, et al.. Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study. PLoS One. 2021, 16:e0247623. 10.1371\/journal.pone.0247623","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqab375","article-title":"Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: The Chronic Renal Insufficiency Cohort","volume":"115","author":"Shea MK","year":"2022","unstructured":"Shea MK, Barger K, Booth SL, et al.. Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: The Chronic Renal Insufficiency Cohort. Am J Clin Nutr. 2022, 115:941-8. 10.1093\/ajcn\/nqab375","journal-title":"Am J Clin Nutr"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071576","article-title":"Vitamin D and chronic kidney disease association with mineral and bone disorder: An appraisal of tangled guidelines","volume":"15","author":"Bover J","year":"2023","unstructured":"Bover J, Mass\u00f3 E, Gifre L, et al.. Vitamin D and chronic kidney disease association with mineral and bone disorder: An appraisal of tangled guidelines. Nutrients. 2023, 15:1576. 10.3390\/nu15071576","journal-title":"Nutrients"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/nu14050925","article-title":"Vitamin K supplementation for prevention of vascular calcification in chronic kidney disease patients: Are we there yet?","volume":"14","author":"Roumeliotis S","year":"2022","unstructured":"Roumeliotis S, Duni A, Vaios V, Kitsos A, Liakopoulos V, Dounousi E. Vitamin K supplementation for prevention of vascular calcification in chronic kidney disease patients: Are we there yet?. Nutrients. 2022, 14:925. 10.3390\/nu14050925","journal-title":"Nutrients"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000611","article-title":"Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder","volume":"29","author":"Egstrand S","year":"2020","unstructured":"Egstrand S, Olgaard K, Lewin E. Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder. Curr Opin Nephrol Hypertens. 2020, 29:367-77. 10.1097\/MNH.0000000000000611","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705692200","article-title":"Thrombomodulin is a clock-controlled gene in vascular endothelial cells","volume":"282","author":"Takeda N","year":"2007","unstructured":"Takeda N, Maemura K, Horie S, et al.. Thrombomodulin is a clock-controlled gene in vascular endothelial cells. J Biol Chem. 2007, 282:32561-7. 10.1074\/jbc.M705692200","journal-title":"J Biol Chem"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.90572.2008","article-title":"Vascular circadian rhythms in a mouse vascular smooth muscle cell line (Movas-1)","volume":"295","author":"Chalmers JA","year":"2008","unstructured":"Chalmers JA, Martino TA, Tata N, Ralph MR, Sole MJ, Belsham DD. Vascular circadian rhythms in a mouse vascular smooth muscle cell line (Movas-1). Am J Physiol Regul Integr Comp Physiol. 2008, 295:R1529-38. 10.1152\/ajpregu.90572.2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071769","article-title":"The vascular circadian clock in chronic kidney disease","volume":"10","author":"Egstrand S","year":"2021","unstructured":"Egstrand S, Mace ML, Olgaard K, Lewin E. The vascular circadian clock in chronic kidney disease. Cells. 2021, 10:1769. 10.3390\/cells10071769","journal-title":"Cells"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22314","article-title":"Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype","volume":"226","author":"Somanath PR","year":"2011","unstructured":"Somanath PR, Podrez EA, Chen J, Ma Y, Marchant K, Antoch M, Byzova TV. Deficiency in core circadian protein Bmal1 is associated with a prothrombotic and vascular phenotype. J Cell Physiol. 2011, 226:132-40. 10.1002\/jcp.22314","journal-title":"J Cell Physiol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00639-9","article-title":"Multiple functions of autophagy in vascular calcification","volume":"11","author":"Zhou X","year":"2021","unstructured":"Zhou X, Xu SN, Yuan ST, et al.. Multiple functions of autophagy in vascular calcification. Cell Biosci. 2021, 11:159. 10.1186\/s13578-021-00639-9","journal-title":"Cell Biosci"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106485","article-title":"BRG1 is involved in vascular calcification in chronic renal disease via autophagy of vascular smooth muscle cells","volume":"26","author":"Feng Y","year":"2023","unstructured":"Feng Y, Yu M, Wang C, et al.. BRG1 is involved in vascular calcification in chronic renal disease via autophagy of vascular smooth muscle cells. iScience. 2023, 26:106485. 10.1016\/j.isci.2023.106485","journal-title":"iScience"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301429R","article-title":"HDAC2 counteracts vascular calcification by activating autophagy in chronic kidney disease","volume":"38","author":"Zhou G","year":"2024","unstructured":"Zhou G, Liu P, Zhang C, et al.. HDAC2 counteracts vascular calcification by activating autophagy in chronic kidney disease. FASEB J. 2024, 38:e23470. 10.1096\/fj.202301429R","journal-title":"FASEB J"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04735-7","article-title":"Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease","volume":"13","author":"Pang Q","year":"2022","unstructured":"Pang Q, Wang P, Pan Y, Dong X, Zhou T, Song X, Zhang A. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Cell Death Dis. 2022, 13:283. 10.1038\/s41419-022-04735-7","journal-title":"Cell Death Dis"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.685748","article-title":"\u03b2-Hydroxybutyric inhibits vascular calcification via autophagy enhancement in models induced by high phosphate","volume":"8","author":"Liang J","year":"2021","unstructured":"Liang J, Huang J, He W, Shi G, Chen J, Huang H. \u03b2-Hydroxybutyric inhibits vascular calcification via autophagy enhancement in models induced by high phosphate. Front Cardiovasc Med. 2021, 8:685748. 10.3389\/fcvm.2021.685748","journal-title":"Front Cardiovasc Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12120811","article-title":"Effects of chronic kidney disease and uremic toxins on extracellular vesicle biology","volume":"12","author":"Yaker L","year":"2020","unstructured":"Yaker L, Kamel S, Ausseil J, Boullier A. Effects of chronic kidney disease and uremic toxins on extracellular vesicle biology. Toxins (Basel). 2020, 12:811. 10.3390\/toxins12120811","journal-title":"Toxins (Basel)"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2020.1781427","article-title":"Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins","volume":"9","author":"Boyer MJ","year":"2020","unstructured":"Boyer MJ, Kimura Y, Akiyama T, et al.. Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins. J Extracell Vesicles. 2020, 9:1781427. 10.1080\/20013078.2020.1781427","journal-title":"J Extracell Vesicles"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12040229","article-title":"Indoxyl sulfate, a uremic endotheliotoxin","volume":"12","author":"Lano G","year":"2020","unstructured":"Lano G, Burtey S, Sall\u00e9e M. Indoxyl sulfate, a uremic endotheliotoxin. Toxins (Basel). 2020, 12:229. 10.3390\/toxins12040229","journal-title":"Toxins (Basel)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1159\/000496796","article-title":"Indoxyl sulfate-induced extracellular vesicles released from endothelial cells stimulate vascular smooth muscle cell proliferation by inducing transforming growth factor-beta production","volume":"56","author":"Ryu JH","year":"2019","unstructured":"Ryu JH, Jeon EY, Kim SJ. Indoxyl sulfate-induced extracellular vesicles released from endothelial cells stimulate vascular smooth muscle cell proliferation by inducing transforming growth factor-beta production. J Vasc Res. 2019, 56:129-38. 10.1159\/000496796","journal-title":"J Vasc Res"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5195","article-title":"Exosomal STAT1 derived from high phosphorus\u2011stimulated vascular endothelial cells induces vascular smooth muscle cell calcification via the Wnt\/\u03b2\u2011catenin signaling pathway","volume":"50","author":"Qin Z","year":"2022","unstructured":"Qin Z, Li Y, Li J, et al.. Exosomal STAT1 derived from high phosphorus\u2011stimulated vascular endothelial cells induces vascular smooth muscle cell calcification via the Wnt\/\u03b2\u2011catenin signaling pathway. Int J Mol Med. 2022, 50:139. 10.3892\/ijmm.2022.5195","journal-title":"Int J Mol Med"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1193660","article-title":"Extracellular vesicles in atherosclerosis and vascular calcification: The versatile non-coding RNAs from endothelial cells and vascular smooth muscle cells","volume":"10","author":"Yu F","year":"2023","unstructured":"Yu F, Duan Y, Liu C, Huang H, Xiao X, He Z. Extracellular vesicles in atherosclerosis and vascular calcification: The versatile non-coding RNAs from endothelial cells and vascular smooth muscle cells. Front Med (Lausanne). 2023, 10:1193660. 10.3389\/fmed.2023.1193660","journal-title":"Front Med (Lausanne)"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2023.2266381","article-title":"Future treatment of vascular calcification in chronic kidney disease","volume":"24","author":"Cozzolino M","year":"2023","unstructured":"Cozzolino M, Maffei Faccioli F, Cara A, et al.. Future treatment of vascular calcification in chronic kidney disease. Expert Opin Pharmacother. 2023, 24:2041-57. 10.1080\/14656566.2023.2266381","journal-title":"Expert Opin Pharmacother"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072466","article-title":"The role of vitamin D in modulating mesenchymal stem cells and endothelial progenitor cells for vascular calcification","volume":"21","author":"Hou YC","year":"2020","unstructured":"Hou YC, Lu CL, Zheng CM, et al.. The role of vitamin D in modulating mesenchymal stem cells and endothelial progenitor cells for vascular calcification. Int J Mol Sci. 2020, 21:2466. 10.3390\/ijms21072466","journal-title":"Int J Mol Sci"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.4103\/tcmj.tcmj_100_22","article-title":"Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence","volume":"35","author":"Lin YL","year":"2023","unstructured":"Lin YL, Hsu BG. Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence. Tzu Chi Med J. 2023, 35:44-50. 10.4103\/tcmj.tcmj_100_22","journal-title":"Tzu Chi Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/273086-pathogenesis-and-mechanism-of-uremic-vascular-calcification","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T03:11:49Z","timestamp":1721272309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/273086-pathogenesis-and-mechanism-of-uremic-vascular-calcification"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":91,"URL":"https:\/\/doi.org\/10.7759\/cureus.64771","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}